Home › NDC Lookup › RxCUI directory › RxCUI 616283

Sunitinib 12.5 MG Oral Capsule [Sutent] — RxCUI 616283

RxNorm drug concept · Semantic branded drug
RxCUI 616283 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI616283
Official nameSunitinib 12.5 MG Oral Capsule [Sutent]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asSutent 12.5 MG Oral Capsule; Sutent 12.5 MG (as sunitinib malate 16.7 MG) Oral Capsule
FDA products mapped4
Package NDCs mapped4
Reported Medicaid activity (SDUD)39 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Sunitinib: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's actually quite different from traditional chemotherapy. Sunitinib is what we call a targeted therapy — it blocks specific proteins on cancer cells that tell them to grow and b...
  • What exactly does sunitinib do — is it like regular chemotherapy?
  • That's a great question. The 4-weeks-on, 2-weeks-off schedule — called Schedule 4/2 — is used for GIST and kidney cancer to give your body a chance to recover from side effects bef...
  • I noticed I take it for 4 weeks and then stop for 2 weeks. Why the break?
📖 Read our full Sunitinib guide →

🕸️ Concept Web — How Sunitinib 12.5 MG Oral Capsule [Sutent] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Sunitinib 12.5 MG Oral Capsule [Sutent] RxCUI 616283

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Sunitinib 357977
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Sutent 616274
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sunitinib Oral Capsule 616278
    • Sunitinib Oral Product 1160852
    • Sunitinib Pill 1160853
    • Sunitinib Oral Capsule [Sutent] 616282
    • Sutent Oral Product 1185474
    • Sutent Pill 1185475
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Sunitinib 12.5 MG Oral Capsule SCD · 616279
  • Sunitinib 12.5 MG SCDC · 616277
  • Sunitinib Oral Capsule SCDF · 616278
  • Sunitinib Oral Product SCDG · 1160852
  • Sunitinib Pill SCDG · 1160853

Brand-Name Concepts

  • Sunitinib 12.5 MG [Sutent] SBDC · 616281
  • Sunitinib Oral Capsule [Sutent] SBDF · 616282
  • Sutent Oral Product SBDG · 1185474
  • Sutent Pill SBDG · 1185475
  • Sutent BN · 616274

📦 FDA Products & Package NDCs

4 products · 4 package NDCs
4 package NDCs map to RxCUI 616283 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00069-0550-38 28 CAPSULE in 1 BOTTLE (0069-0550-38) SUTENT Pfizer Laboratories Div Pfizer Inc 2006-01-26
00069-0770-38 28 CAPSULE in 1 BOTTLE (0069-0770-38) SUTENT Pfizer Laboratories Div Pfizer Inc 2006-01-26
00069-0830-38 28 CAPSULE in 1 BOTTLE (0069-0830-38) SUTENT Pfizer Laboratories Div Pfizer Inc 2014-07-12
00069-0980-38 28 CAPSULE in 1 BOTTLE (0069-0980-38) SUTENT Pfizer Laboratories Div Pfizer Inc 2006-01-26
Observed labelers: Pfizer Laboratories Div Pfizer Inc (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.